Burrill promotes Aynechi, Vygantas, and Patel; UVA Patent Foundation honors Mugler and Brookeman as inventors of the year; and Balser to succeed Jacobson as vice chancellor for health affairs at Vanderbilt
The data demonstrate that siRNAs that are 21 nucleotides in length or longer suppress both hemangiogenesis and lymphangiogenesis in vivo, regardless of their targets or sequences, due to the activation of TLR3.
The Hunter Medical Research Institute was started to bring together biomedical and clinical scientists — and the results have been so positive that it has become a model for how to accomplish translational research.
Based on their assessment of SNP data for several complex diseases, researchers from the University of Pittsburgh and the University of California at Los Angeles warn that genetic tests based on existing GWAS may not be refined enough to accurately predict individual disease risk.
Navigenics’ lower-priced program to incorporate genetic risk data in patients’ annual medical checkup raises questions as to whether personal genomics firms should be broadly marketing their services to physicians.